In cells insulin stimulates autophosphorylation of the insulin receptor on tyrosine and its phosphorylation on serine and threonine by poorly characterized kinases. Recently we have achieved co-purification of the insulin receptor with insulinstimulated insulin receptor serine kinase activity. We now show that the co-purified serine kinase activity can be removed by NaCl washing and reconstituted by adding back the NaCl eluate. Reconstitution enabled higher serine phosphorylation than achieved with the co-purified preparation. Myelin basic protein was discovered to be a potent substrate for insulin-stimulated serine phosphorylation by the co-purified preparation, with the activity responsible having similar properties to the serine kinase activity towards the receptor. Myelin basic protein was also phosphorylated on serine by the NaCl eluate. Myelin basic
INTRODUCTION
The insulin receptor is an insulin-stimulated tyrosine-specifi.c protein kinase. The tyrosine kinase catalyses the very rapid autophosphorylation of its own fl-subunit on multiple tyrosines.
The tyrosine autophosphorylation functions in turn to activate the insulin receptor tyrosine kinase to phosphorylate other proteins (for reviews see refs. [1, 2] ). In intact cells the tyrosine autophosphorylation is followed by an increase in phosphorylation of the ,8-subunit on serine and threonine residues [3] [4] [5] . The serine and threonine phosphorylations have not been observed in many studies in which purified insulin receptors have been phosphorylated in vitro. This suggests that the serine and threonine phosphorylations require components that are distinct from the insulin receptor and that are usually absent from cellfree systems. The functional consequences of the insulinstimulated serine/threonine phosphorylation of the insulin receptor are uncertain.
Comparisons of the phosphorylation patterns of the insulin receptor in different cell types have raised the possibility that the insulin receptor can be phosphorylated within cells by a number of different serine/threonine kinases [6] . As these serine/ threonine kinases may play important roles in the intracellular transmission of the insulin signal and in the regulation of insulin receptor function, characterization of the kinases is important.
Our laboratory showed for the first time that it was possible to co-purify a high insulin-stimulated insulin receptor serine kinase (IRSK) activity with the insulin receptor by refining the protocol for isolating the insulin receptor [7] . The co-purified IRSK protein phosphorylated by the co-purified preparation or the NaCl eluate gave the same set of phosphoserine peptides. The major myelin basic protein serine kinase activity in the NaCl eluate co-purified exactly on Mono Q with the activity that restored insulin-stimulated insulin receptor serine phosphorylation. These results provide strong evidence for the true separation of the serine kinase from the insulin receptor and the distinctiveness of the serine kinase activity from the insulin receptor tyrosine kinase and mitogen-activated protein kinases. The procedures developed for the isolation of the serine kinase and the establishment of an effective in vitro substrate should allow purification of the kinase. The protocols also provide flexible systems for identifying the functions of the insulinstimulated serine phosphorylations and the respective kinase(s). activity or activities appeared to be novel [8] . Baltensperger et al. [9] have, however, challenged the notion that such co-purified serine kinases are actually distinct from the insulin receptor and have argued that the insulin receptor tyrosine kinase itself is responsible for the insulin-stimulated insulin receptor serine phosphorylation seen in vitro.
To understand fully the roles of insulin-receptor-associated serine kinases, their isolation and characterization are required. We now report the successful removal, isolation and reconstitution of the co-purified IRSK activity and the discovery that myelin basic protein (MBP) is an excellent substrate for the kinase in vitro. The protocols developed and availability of MBP as a substrate should allow purification of the IRSK activity and thereby delineation of its role and mechanism of activation.
MATERIALS AND METHODS Materials
Triton X-100, N-acetylglucosamine, phospho amino acids, aprotinin, PMSF, benzamidine, BSA, human y-globulin, pig insulin, trypsin (treated with TosPheCHCl2), MBP 
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International, Amersham, Bucks., U.K. Pig 1251-insulin was from NEN-Du Pont, Stevenage, Herts., U.K. Cellulose thin-layer plates (20 cm x 20 cm) were from Kodak, Kirkby, Liverpool, U.K. Phosphocellulose paper was from Whatman, Maidstone, Kent, U.K. Peptides 1142-11-53 (Thr-Arg-Asp-Ile-Tyr-Glu-ThrAsp-Tyr-Tyr-Arg-Lys) and 1290-1298 (Leu-Asp-Arg-Ser-SerHis-Cys-Gln-Arg) of the insulin receptor were synthesized manually using a solid-phase method [8] .
Preparation of solubilized placental membranes
Human placentae were obtained within 1 h of delivery. All procedures were carried out at 4 'C. Placentae were trimmed of amnion and chorion, washed with 0.25 M sucrose and cut into small pieces. The pieces were then homogenized for 3 x 1 min in a Waring blender in 1 vol. of 50 mM Tris/HCl, pH 7.4, containing 0.25 M sucrose and 1 mM PMSF. The homogenate was centrifuged at 15000 g for 20 min, and the supernatants were collected and centrifuged at 100000 g for 1 h. The pellets were suspended in 10 vol. of 50 mM Tris/HCl, pH 7.4, containing 1 mM PMSF by, homogenization by hand, and centrifuged at 100000 g for 1 h. The sedimented membranes were resuspended by homogenization by-hand in 2 vol. of 50 mM Tris/HCl, pH 7.4, containing 1 mM PMSF, separated into 1.5 ml batches and stored at -70 'C. Typically 1-1.5 g of membranes were obtained per placenta. Membranes (700 mg) were solubilized in a final volume of 30 ml of 50 mM Tris/HCl, pH 7.4, containing 2 % Triton X-100, 0.1 mg of aprotinin/ml and 0.35 mg of PMSF/ml by homogenization by hand, followed by stirring for 2.5 h. The mixture was then centrifuged at 200000 g for 60 min and the supernatant collected.
Preparation of Insulin receptors with IRSK activity and stripped of IRSK activity Insulin receptors were immobilized by recycling the solubilized membranes (30 ml) three times through a 5 ml wheat-germagglutinin-agarose column, which had been equilibrated with 50 mM Tris/HCl, pH 7.4, containing 0.1 % Triton X-100 and 0.1 mM PMSF. The column was then washed with 150 ml of the equilibration buffer. For the preparation of insulin receptors stripped of IRSK activity, the immobilized insulin receptors were washed with 20 ml Of the equilibration buffer containing 1 M NaCl to remove IRSK activity. For the preparation of insulin receptors co-purified with IRSK activity, the immobilized insulin receptors were washed with 20 ml of equilibration buffer without NaCl. Columns were then washed with 100 ml ofthe equilibration buffer followed by elution of insulin receptors with 15 ml of the buffer containing 0.5 M N-acetylglucosamine. The proteincontaining fractions, determined with the Bradford assay (standardized with BSA), were pooled, separated into 150,1 batches and stored at -70 'C. The yield of protein was similar for the preparation of the two types of insulin receptors and was typically 5-10 mg with a protein concentration of 1 mg/ml in the pooled fractions. In addition, the molar yield of insulin receptors determined from the concentration of high-affinity binding sites in insulin-binding assays performed as recommended by Pang and Shafer [10] was similar for the two types of insulin receptor preparation, being 15-17 pmol/mg of protein. In experiments using the protein peak eluted by washing the immobilized insulin receptors with 1 M NaCl, the protein peak was first dialysed at 4 'C for 18 h against 50 mM Tris/HCl, pH 7.4, containing 0.1 % Triton X-100 and 0.1 mM PMSF; the dialysed protein peak is FPLC For FPLC on Mono Q, a column (Pharmacia HR 5/5, average particle size 10 ,M) was equilibrated at a flow rate of 1 ml/min with 20 mM Tris/HCl, pH 7.5, containing 2 mM EDTA, 2 mM EGTA, 0.1 mM Na2VO4, 1 mM dithiothreitol, 0.2 mM PMSF and 1 mM benzamidine. The dialysed NaCl eluate (5-10 ml) was applied to the column using a superloop and washed on to the column with the buffer used to equilibrate the column. The column was developed at a flow rate of 1 ml/min with a 30 ml linear 0-0.5 M NaCl gradient in the buffer used to equilibrate the column. Fractions of 1 ml were collected into tubes containing ethylene glycol and Tween 20 [final concentrations of 10 % (v/v) and 0.05 % (v/v), respectively].
Phosphorylation and reconstitution of insulin receptors
The indicated amounts of insulin receptors were incubated for O min at 22°C with or without 150 nM insulin in 70,u of 50 mM Tris/HCl, pH 7.4, containing 0.1 % Triton X-100 in the presence of 10 mM MgCl2, 2 mM MnCl2 and 1 mM dithiothreitol. Na2VO4 (30-50 1M) was also present unless the samples were destined for protein tyrosine phosphatase treatment.
[y-32P]ATP (approx. 225 ,M; 5-10 c.p.m./fmol) was then added, and, after incubation for the indicated times at 22°C, phosphorylations were terminated by adding Laemmli sample buffer [62.5 mM Tris/HCl, pH 7.4, 1 % (w/v) SDS, 19 mg/ml dithiothreitol, 0.002% (w/v) Bromophenol Blue, 20% (w/v) sucrose] and boiling for 2 min. In reconstitution experiments, the indicated additions (or buffer alone) were present throughout the incubation period. Separation of insulin receptor f-subunits on 4% acrylamide stacking/7.5 % acrylamide resolving gels and autoradiography were as described previously [7] .
Phosphorylation of exogenous substrates Phosphorylations employing MBP, histone 2b or peptide 1290-1298 of the insulin receptor as substrates, at the concentrations stated, were performed as described above except as indicated in the Figure legends. Incubations involving MBP or histone 2b were either subjected to SDS/PAGE as described above, except that 15 % resolving gels were used, or 0.33 vol. of 8 M acetic acid was added and 30 1l aliquots were spotted on to 4 cm x 1 cm phosphocellulose paper strips. The strips were immediately immersed in 2 litres of 75 mM phosphoric acid and stirred for 5 min. The strips were washed a further five times in this way, dried and counted. For analysis of phosphorylation of peptide 1290-1298, an equal volume of 1 M acetic acid was added. The reaction mixtures were then applied at a flow rate of 1 ml/min to columns of AG1-X2 acetate anion-exchange resin (1 g of resin/ 100 ll of incubation mixture) which had been equilibrated with 10 bed vol. of 1 M acetic acid. The reaction mixtures were washed through the columns with 1 M acetic acid. One ml fractions were collected. Fractions were counted for 32P and the peak fractions pooled. The material was lyophilized and electrophoresed at 400 V for 2.5 h on cellulose thin-layer plates at pH 3.5 (pyridine/acetic acid/water; 1: 10: 189, by vol.). Autoradiograms were obtained at -70°C for 18 h. 32P associated with the peptide was quantified by liquid-scintillation counting of radioactivity.
Phospho amino acid analysis and two-dimensional thin-layer peptide mapping The region of the gel containing the protein band was excised, incubated with 10 ml of 20% (v/v) methanol for 18 h at hereafter referred to as the dialysed NaCl eluate.
37°C and dried at 70°C for 2 h in an oven. Then 2 ml of 50 mM NH4HCO3 containing 100 jug of trypsin (treated with TosPheCH2Cl) was added. The mixture was incubated at 37°C for 6 h, a further 100 /zg of trypsin was added and incubation continued for a further 18 h. The samples were freeze-dried.
For phospho amino acid analysis the 32P-labelled tryptic phosphopeptides were hydrolysed in 6 M HC1 at 1 10°C for 2 h. After addition of 1 ml of water and freeze-drying, the samples were dissolved in lOl of water containing phosphotyrosine, phosphoserine and phosphothreonine, each at 1 mg/ml. Phospho amino acids were separated by electrophoresis on cellulose thinlayer plates at pH 3.5 for 1.5 h at 1 kV. Xylene cyanol was used as a tracking dye. The phospho amino acid standards were identified by reaction with ninhydrin. Autoradiograms were obtained at -70°C for [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] days. 32P associated with phospho amino acids was quantified by densitometric scanning or by excision of the spots and liquid-scintillation counting of radioactivity. Both methods gave similar answers.
For two-dimensional peptide mapping, the 32P-labelled phosphopeptides were dissolved in 20,ul of water and separated on cellulose thin-layer plates by electrophoresis at 400 V for 4 h at pH 3.5 (pyridine/acetic acid/water; 1:10:189, by vol.) in the first dimension and ascending chromatography (pyridine/acetic acid/butanol/water; 10:3:15:12, by vol.) in the second dimension. Autoradiograms were obtained at -70°C for 7 days. For phospho amino acid analysis of tryptic phosphopeptides purified by two-dimensional thin-layer analysis, the peptides were removed by scraping the cellulose. The procedure was then as described above.
Determination of insulin receptor phosphoserine by protein tyrosine phosphatase treatment
In some experiments the 32P incorporated into phosphoserine of the insulin receptor was determined after specific dephosphorylation using a partially purified preparation of protein tyrosine phosphatase lB as described previously [11, 12 ; see also 13]. For this, insulin receptor phosphorylations were terminated by adding EDTA to a final concentration of 10 mM followed by adding sufficient protein tyrosine phosphatase activity to dephosphorylate completely phosphotyrosine residues of the insulin receptor in a 20 min incubation at 30 'C. Samples were then subjected to SDS/PAGE as described above, and the ,-subunit of the insulin receptor located by autoradiography, excised and counted. Control experiments confirmed that under the dephosphorylation conditions employed the phosphotyrosine was completely dephosphorylated whereas the phosphoserine was not significantly dephosphorylated. This method of determining the serine phosphorylation of the insulin receptor was used for the assay of IRSK in fractions eluted from FPLC columns and to estimate the stoicheiometry of serine phosphorylation of the insulin receptor.
Insulin-binding assay
Solubilized insulin receptor (20 ,tg) was incubated with pig 1251_ insulin (20000 c.p.m.) in 50 mM Tris/HCl buffer, pH 7.7, containing 0.1 % BSA in the presence of different concentrations of unlabelled pig insulin (0-10 nM). The final assay volume was 0.2 ml. Non-specific insulin binding was determined in the presence of 5 ,uM unlabelled insulin. The insulin receptor-'25 -insulin complex was separated from free 1251-insulin by adding at 4 'C 0.3 ml of poly(ethylene glycol) (25 %, w/v) and 0.1 ml of human y-globulin (3 mg/ml), vortex mixing and centrifuging at 10000 g for 5 min. Pellets were washed at 4 'C with 0.3 ml of 12.5 % (w/v) poly(ethylene glycol) and counted for radioactivity.
RESULTS

Removal of IRSK activity from the insulin receptor
We have reported previously [7] that it is possible to co-purify the insulin receptor from human placental membranes with IRSK activity. In that study it was observed that inclusion of NaCl in the insulin receptor isolation buffers markedly reduced the IRSK activity that co-purified. This suggested the possibility of using NaCl to strip IRSK activity away from the insulin receptor and thereby isolate it.
To test this, insulin receptors in solubilized human placental membranes were immobilized on wheat-germ-agglutinin-agarose columns and pulse-washed with or without 1 M NaCl. Insulin receptors were then eluted with N-acetylglucosamine (after washing). The recovery of the two types of insulin receptor was similar whether based on the protein yield or the insulin-binding capacity (see also the Materials and methods section). Equal amounts of the insulin receptors, based on insulin binding, were phosphorylated. Analysis by SDS/PAGE (Figure la) showed that the NaCl-washed insulin receptors, after phosphorylation for 30 min, exhibited an approx. 2-fold higher level of insulinstimulated phosphorylation than the non-NaCl-washed insulin receptors. Phospho amino acid analysis (Figure lb) showed that the non-NaCl-washed insulin receptors underwent phosphorylation on both tyrosine and serine. Their phosphoserine/phosphotyrosine ratio after phosphorylation for 20-40 min in the presence of insulin was 0.31+0.08 (mean + S.E.M.; seven observations). NaCl-washed insulin receptors yielded markedly lower levels of insulin-stimulated phosphorylation on serine showing that the insulin receptors were greatly depleted of IRSK activity. The phosphoserine/ phosphotyrosine ratios of the NaCl-washed insulin receptors phosphorylated in the presence of insulin for 20-40 min were 0.01-0.08. The change in the phosphoserine/phosphotyrosine ratio on NaCl washing was due not only to a decrease in phosphoserine but also to an increase in phosphotyrosine. Thus Figure 1 Preparation of insulin receptors stripped of IRSK activity by pulse-washing with NaCI
Insulin receptors in solubilized human placental membranes were immobilized on wheat-germagglutinin-agarose and washed with 150 ml of butter. The immobilized insulin receptors were then either washed with a further 120 ml of the buffer or pulse-washed with 20 ml of the butter containing 1 M NaCI followed by washing with 100 ml of the buffer. Insulin receptors were then eluted with N-acetylglucosamine. . i . . NaCl washing stripped away IRSK activity and increased insulin receptor autophosphorylation on tyrosine.
Reconstitution of IRSK activity to stripped insulin receptors
This was achieved by adding back the dialysed NaCl eluate followed by phosphorylation. Reconstituted insulin receptors exhibited diminished total phosphorylation, as analysed by SDS/PAGE, with larger amounts of the dialysed NaCl eluate causing greater inhibition (Figure 2a) . Phospho amino acid analysis showed that reconstitution increased insulin receptor phosphorylation on serine, with larger amounts of the dialysed NaCl eluate giving greater serine phosphorylation (Figure 2b ). The reconstituted serine phosphorylation was insulin-stimulated.
Thus reconstitution restored IRSK activity to the stripped insulin receptors.
The phosphoserine/phosphotyrosine ratios of the reconstituted insulin receptors after phosphorylation for 20-40 min in the presence of insulin ranged from 0.08 to 0.68 with 0.1-0.35 mg/ml dialysed NaCl eluate (Figure 2b and Table  1 ). The phosphoserine/phosphotyrosine ratios were up to 2-fold higher with the reconstituted insulin receptors than with the nonNaCl-washed insulin receptors ( Table 1) . Measurement of the stoicheiometries of serine phosphorylation showed that reconstitution enabled a higher absolute amount ofinsulin receptor serine phosphorylation to be achieved than that obtained using the non-NaCl-washed insulin receptors. The stoicheiometries of serine phosphorylation were estimated after specific dephosphorylation of tyrosine residues with protein tyrosine phosphatase l B. This approach overcame the problem, associated with normal phospho amino acid analysis, of the potentially greater acid lability of phosphotyrosine than phosphoserine. Phospho amino acid analysis showed that, under the dephosphorylation conditions used, dephosphorylation of phosphoserine was not significant whereas dephosphorylation of phosphotyrosine was complete (see the Materials and methods section). Stoicheiometries of serine phosphorylation (mol/mol of insulin receptor; mean+S.E.M.; three observations) were 1.44 + 0.44 for the stripped insulin receptors reconstituted with 0.35 mg/ml dialysed NaCl eluate and 0.80 + 0.20 for the nonNaCl-washed insulin receptors. The values were calculated from the 32P associated with the fl-subunit, as determined by SDS/PAGE of the protein tyrosine phosphatase-treated receptor, and from insulin binding assays to determine the molarity of the insulin receptor. The latter involved determining the concentration of high-affinity insulin-binding sites and using a value of one high-affinity insulin-binding site per a2,f2 tetramer [7, 10] .
Reconstitution not only increased phosphorylation on serine but also decreased autophosphorylation on tyrosine. Assays against histone after insulin receptor phosphorylation (Table 1) , which is a measure of insulin receptor activation, showed that reconstitution also inhibited exogenous insulin receptor tyrosine kinase activity, with larger amounts of the dialysed NaCl eluate causing greater inhibition. Thus the changes in insulin receptor autophosphorylation were mirrored by changes in insulin receptor activation.
The dialysed NaCl eluate did not contain insulin receptors, as judged by the lack of autophosphorylation (Figure 2a) . Boiling of the dialysed NaCl eluate before reconstitution removed the ability of the dialysed NaCl eluate both to restore serine phosphorylation of the insulin receptor and to inhibit insulin receptor tyrosine kinase activity. Thus the dialysed NaCl eluate appeared to contain a protein factor or factors responsible for the increased insulin receptor phosphorylation on serine and inhibition of tyrosine kinase activity. The protein factor or factors could be the IRSK or modulators of IRSK or tyrosine kinase activity. Experiments aimed at distinguishing between these possibilities together with the discovery of an excellent in vitro substrate for the IRSK are described below.
Are the changes in serine phosphorylation of the insulin receptor responsible for the observed alterations In the insulin receptor tyrosine kinase activity? To investigate the role of serine phosphorylation in mediating the changes in tyrosine autophosphorylation, the time courses of phosphorylation of the insulin receptor were carefully examined IRSK activity compared with the reconstituted insulin receptors, for which significantly different levels of serine phosphorylation were obtained. These results suggest that the dialysed NaCl eluate contained a modulator of insulin receptor tyrosine autophosphorylation that was distinct from IRSK.
MBP acts as a potent in vitro substrate for IRSK and distinguishes the kinase from mitogen-activated protein (MAP) kinases Using the insulin receptor co-purified with IRSK activity, MBP was observed to be a substrate for insulin-stimulated phosphorylation on both serine and tyrosine (Figure 3) . Phosphorylation of MBP on serine was stimulated 2-5-fold by insulin, which is similar to the degree of insulin stimulation of ,-subunit phosphorylation on serine found with the co-purified preparation of insulin receptor/IRSK. To examine whether the insulin-stimulated phosphorylation of MBP on serine is catalysed by IRSK and not another kinase, IRSK activity was manipulated and the effect on the serine phosphorylation of MBP examined. We have previously shown, using the insulin receptor/IRSK preparation, that inhibition of insulin receptor tyrosine kinase activity by a range of methods results in inhibition of the ability of insulin to stimulate serine phosphorylation of the insulin receptor [8] . The methods of inhibition included the use of peptide 1142-1153 of the insulin receptor, which acts as a competing substrate, phosphate or Mg2+ in the absence of Mn2+ during phosphorylation. Table 3 shows that these agents caused a parallel inhibition of insulin-stimulated serine phosphorylation of the insulin receptor f8-subunit and MBP. The extent of the inhibition of the serine phosphorylation and the sensitivity of the inhibition to various concentrations of peptide 1142-1153 were closely similar with both the fl-subunit and MBP as substrates.
Thus it was likely that the IRSK was responsible for catalysing the observed serine phosphorylation of MBP. As the agents used to manipulate IRSK activity also affect insulin receptor tyrosine kinase activity, it could be argued that the serine phosphorylation of MBP was due to a serine-phosphorylating activity of the insulin receptor tyrosine kinase. This was unlikely because this activity with exogenous substrates is extremely low [9, 14] and because the sensitivities of insulin receptor autophosphorylation on tyrosine and phosphorylation on serine to the agents used are significantly different [8] . In addition, insulin receptors lacking IRSK activity phosphorylated MBP exclusively on tyrosine (Figure 4) , and the isolated serine kinase preparation, which was devoid of insulin receptors, yielded the same pattern of serine phosphorylation of MBP as that obtained with the co-purified preparation (see below). Table 4 shows that MBP was a much better substrate for serine phosphorylation by the co-purified insulin receptor/IRSK preparation than the other substrates tested, namely histone 2b and synthetic peptide 1290-1298 of the insulin receptor, which contains the serine-phosphorylation site 1293/4.
MBP phosphorylated by the insulin receptor/IRSK preparation did not contain phosphothreonine (Figures 3 and 4) . MBP is a well-characterized substrate for MAP kinases. As p42 MAP kinase and p44 MAP kinase phosphorylate MBP exclusively on a threonine residue [15, 16] , and not on serine, this indicates that the IRSK is distinct from these two MAP kinase isoforms. IRSK activity has previously been shown to be distinct from a number of other serine kinases [8] and thus remains a novel entity.
Serine phosphorylation of MBP by the dialysed NaCi eiuate Incubation of the dialysed NaCl eluate with MBP and [y_32P]_ ATP showed that it directly phosphorylated MBP on serine but not tyrosine or threonine (Figure 3 ). This phosphorylation was not stimulated by insulin. In order to examine whether this serine phosphorylation is catalysed by a basal activity of the IRSK, two approaches were employed.
In the first, phosphorylated MBP was subjected to twodimensional thin-layer tryptic peptide mapping ( Figure 5 The substrates were phosphorylated at the concentrations indicated using 12 pmol/ml insulin receptor co-purified with IRSK activity in the presence of insulin or 0.3 mg/mI dialysed NaCI eluate in the absence of insulin. Aliquots of 15 u1 were assayed. Where MBP and histone 2b were both serine and tyrosine phosphorylated, the serine phosphorylation was calculated by applying the phosphoserine/phosphotyrosine ratio determined by phospho amino acid analysis to the 32P incorporated into the protein. was assayed by reconstitution with insulin receptors stripped of this activity. To enable the routine assay of column fractions, a simplified assay for serine phosphorylation of the receptor was employed which involved specific dephosphorylation of tyrosine residues with protein tyrosine phosphatase B (see above). Figure  6 shows that nearly all the MBP serine kinase and IRSK activities in the dialysed NaCl eluate bound to Mono Q. Elution of the column with an NaCl gradient gave one major and several minor peaks of MBP serine kinase activity. The major peak was eluted at approx. 310 mM NaCl exactly with the IRSK activity. These results provide strong evidence that MBP acts as an in vitro substrate for IRSK, that MBP can be used to assay the basal activity of the kinase and that stripping insulin receptors of IRSK activity by NaCl washing represents removal of the actual IRSK protein rather than a protein that modulates its activity. It follows that the reconstitution of IRSK to the stripped insulin receptors is the result of the kinase, and not a protein that modulates its activity, being added back. The ability to assay basal insulin receptor serine kinase activity with MBP will facilitate the purification of the kinase. Table 4 compares the initial rates and stoicheiometries of phosphorylation of several substrates by the serine kinase activity in the dialysed NaCl eluate. As found for the insulin receptor/IRSK preparation, MBP was a markedly more effective substrate for serine phosphorylation than either histone 2b or the synthetic peptide 1290-1298 of the insulin receptor. DISCUSSION A protocol is described for removing IRSK activity from insulin receptors by pulse-washing insulin receptors from human placental membranes immobilized on wheat-germ-agglutininagarose with NaCl. Reconstitution of the dialysed NaCl eluate with the stripped insulin receptors restored the insulin-stimulated insulin receptor serine phosphorylation. The amount of insulin receptor serine phosphorylation could be varied by adjusting the amount of dialysed NaCl eluate used in the reconstitution, and it was possible to increase the seine phosphorylation of the insulin receptor by approx. 2-fold compared with that obtained on phosphorylation of insulin receptors co-purified with IRSK activity (Table 1) . Stoicheiometries of serine phosphorylation of up to 0.72+ 0.22 mol/mol of f-subunit were obtained with the reconstituted insulin receptor.
MBP was discovered to be an efficient substrate for insulinstimulated serine phosphorylation by the co-purified preparation, with the activity responsible having similar properties to those of the serine kinase activity towards the insulin receptor. MBP was also phosphorylated on serine by the dialysed NaCl eluate. Twodimensional maps of MBP phosphorylated by the co-purified preparation or the dialysed NaCl eluate revealed the same set of phosphoserine peptides. Chromatography on Mono Q showed that the major MBP serine kinase activity in the dialysed NaCl eluate co-purified exactly with the activity that restored insulinstimulated serine phosphorylation of the insulin receptor. These results strongly suggest that the NaCl wash produced isolation of the actual IRSK protein from the insulin receptor rather than separation of a factor that modulated its activity. It follows that IRSK is an entity distinct from the insulin receptor.
Czech and co-workers [9] , using insulin receptors purified from Sf9 cells after infection with a recombinant baculovirus, have, however, suggested that the insulin receptor tyrosine kinase is able to catalyse low-level autophosphorylation of its own ,f-subunit on serine. However, their preparative procedures involved concentrations of NaCl that would have washed away the IRSK discussed in the present work. In addition, this group of workers [17, 18] have identified Ser-1293/4 of the f-subunit as the preferred site or sites of phosphorylation. In contrast, the IRSK described here utilizes these serines only as minor sites of phosphorylation [19, 20] . Although we do not dispute the possibility that the insulin receptor tyrosine kinase can catalyse lowlevel insulin-stimulated insulin receptor serine phosphorylation, considerably higher insulin-stimulated insulin receptor serine phosphorylation is found in both cells [4, 21] , as pointed out by Czech and co-workers [9] , and the in vitro systems described in the present work, consistent with the involvement of serine kinases other than the insulin receptor tyrosine kinase. The distinction of the present IRSK from the insulin receptor tyrosine kinase was further supported by the manipulation ofinsulin receptor tyrosine and serine phosphorylation in opposing directions in reconstitutions and after removal of IRSK activity (Figures l b and  2b) .
Lewis et al. [17] first proposed that activation by insulin of an IRSK activity involved a direct increase in its catalytic activity based on the observation of insulin-stimulated serine phosphorylation of exogenous substrates. However, this serine kinase activity now appears to be attributable to the insulin receptor tyrosine kinase. The results in the present paper show insulin-stimulated serine phosphorylation of MBP by an IRSK activity that is physically distinct from the insulin receptor. Thus the present results provide evidence for the first time that genuine IRSK activity is activated by insulin by a mechanism involving a direct increase in catalytic activity per se rather than insulininduced serine phosphorylation of the insulin receptor merely as the result of it becoming a better substrate for the kinase. It will be important in future studies to test whether the increase in IRSK activity is due to, for example, phosphorylation on tyrosine or occurs via an interaction with the insulin receptor such as through src homology 2 and/or src homology 3 domains. Preincubation of solubilized insulin receptors with ATP and insulin as per the standard phosphorylation protocol before the isolation of the serine kinase activity, with 50,M vanadate present throughout the isolation procedure, did not lead to a greater activity in the serine kinase fraction (not illustrated). This may favour the latter type of mechanism, but incomplete inhibition of protein tyrosine phosphatase activity throughout the approx. 20 h required to isolate the serine kinase fraction or the presence ofvanadate-insensitive protein tyrosine phosphatase activity are possible.
Direct evidence on the nature of the function of insulinstimulated serine phosphorylation of the insulin receptor is lacking. Basal serine phosphorylation of the insulin receptor in cells has been reported to inhibit subsequent insulin-stimulated autophosphorylation on tyrosine [4] . Phorbol esters stimulate insulin receptor serine phosphorylation in cells but the effects of this on tyrosine kinase activity are controversial. In Fao hepatoma cells, phorbol ester-induced serine phosphorylation was reported to inhibit insulin receptor tyrosine kinase activity [22] . However, overexpression ofprotein kinase C isoenzymes resulted in hyperphosphorylation of the insulin receptor on serine but no inhibition of tyrosine kinase activity [23] . One explanation for the different results is that different serines may be phosphorylated in different cell types. A further complication is that the serines phosphorylated in response to insulin may also differ. In the present work changes in insulin-stimulated insulin receptor serine phosphorylation as a consequence of depletion or reconstitution of IRSK activity and the effect on insulin receptor tyrosine autophosphorylation initially raised the possibility that the insulin-stimulated serine phosphorylation inhibits tyrosine kinase activity. However, detailed time-course and dose-response studies showed that the extent of insulin-stimulated serine phosphorylation did not correlate well with inhibition of tyrosine kinase activity. Indeed in time-course studies, lowered tyrosine kinase activity was evident before the onset of the serine phosphorylation was detected (Table 2 ). Thus it appeared that the alterations in the tyrosine kinase activity were due, at least in part, to the removal/reconstitution of another modulator or modulators. The presence of vanadate in the incubations indicated that the modulator protein was not a protein tyrosine phosphatase [11] . Candidates for the tyrosine kinase modulator protein include the membrane protein PCI [24] and the phosphoprotein a-2-HS-glycoprotein [25] . The results do not, however, necessarily exclude some role for insulin-stimulated insulin receptor seine phosphorylation in inhibition of tyrosine kinase activity. However, it is noteworthy that treatment of cells with okadaic acid, a serine/threonine protein phosphatase inhibitor, did not interfere with insulin-induced insulin receptor autophosphorylation or with tyrosine kinase activity towards artificial substrates [26] .
In summary, this work describes how an IRSK can be physically separated from the insulin receptor, isolated and reconstituted to produce high levels of serine phosphorylation in vitro. In addition, a potent in vitro substrate (MBP) for the seine kinase is described. Together these should allow purification of an elusive insulin-stimulated serine kinase activity and establish a flexible in vitro system for studying the function of serine phosphorylation.
